Global Artificial Intelligence in Breast Imaging Market is valued at USD 348.9 Million in 2022 and expected to reach USD 2007.3 Million by 2029 with a CAGR of 28.4% over the forecast period.
Global Artificial Intelligence in Breast Imaging Market: Global Size, Trends, Competitive, Historical & Forecast Analysis, and 2023-2029- Growing prevalence of breast cancers, rising government support and growing technological advancement are some of the major factors driving the growth of the Global Artificial Intelligence in Breast Imaging Market.
Artificial intelligence (AI) in breast imaging refers to the use of machine learning algorithms and other AI technologies to assist radiologists in the detection and diagnosis of breast cancer and other breast diseases. AI algorithms can be trained using large datasets of mammograms and other breast images, enabling them to identify patterns and anomalies that may be difficult for human radiologists to detect. For example; AI algorithms can be trained to identify suspicious lesions, calcifications, and other features that may be indicative of breast cancer.
AI has the potential to transform breast imaging by improving the accuracy and efficiency of breast cancer screening and diagnosis and helping to reduce the burden on overworked radiologists. One of the most promising applications of AI in breast imaging is the use of AI-based risk prediction models.
These models can be used to predict a woman's risk of developing breast cancer based on a range of factors, including age, family history, and genetic markers. This information can then be used to help guide screening and diagnostic decisions, potentially leading to earlier detection and improved outcomes for patients.
The Covid-19 pandemic has had mixed impact on the global artificial intelligence in breast imaging market. During Covid-19 pandemic, the global economy experiencing a significant slowdown and many healthcare providers facing financial difficulties, there has been a decrease in investment in AI-based breast imaging technologies. In addition, disruptions to supply chains and manufacturing processes have led to delays in the development and deployment of new AI-based breast imaging solutions. However, the pandemic has accelerated the adoption of telehealth and other remote healthcare technologies, including AI-based breast imaging solutions.
The global artificial intelligence in breast imaging market is segmented based on radiology type, technique, Application, end user and region and country level. Based on radiology type, the global artificial intelligence in breast imaging market is segmented into mammography, breast imaging, neurology, colonography, cardiovascular, head CT scan, and rest of the body. Mammography is subdivided into digital mammography in 2D, digital mammography in 3D. Breast imaging is subdivided into interpretive task and noninterpretive task. Based on technique, the global artificial intelligence in breast imaging market is segmented into x-rays, computed tomography (CT), magnetic resonance imaging (MRI), ultrasound, positron emission tomography (PET), others. Based on application, the global artificial intelligence in breast imaging market is segmented into computer-aided diagnosis, clinical decision support, quantitative analysis tools, computer-aided detection. Based on end-user, the global artificial intelligence in breast imaging market is segmented into hospitals, diagnostic imaging centers, breast care centers, others.
The regions covered in the global artificial intelligence in breast imaging market report are North America, Europe, Asia-Pacific, Latin America, and the rest of the World. Based on country level, the market of global artificial intelligence in breast imaging is sub divided into U.S., Mexico, Canada, U.K., France, Germany, China, Italy, India, Japan, Southeast Asia, Middle East Asia (Saudi Arabia, UAE, Egypt) GCC, Africa, etc.
Some major key players for the global artificial intelligence in breast imaging market report cover prominent players like -
One of the major factors driving the growth of the global artificial intelligence in breast imaging market is the increasing prevalence of breast cancer. Breast cancer is the most general cancer amongst women globally. For instance; according to the World Health Organization, an estimated 2.3 million new cases of breast cancer were diagnosed in 2020, accounting for 11.7% of all cancer cases. The increasing prevalence of breast cancer worldwide is driving the demand for more accurate and efficient breast cancer screening and diagnostic services, which can be facilitated by AI in breast imaging.
In addition, the rising geriatric population is another factor that boosts artificial intelligence in breast imaging market. The risk of breast cancer increases as individuals age, and as the population ages, the incidence of breast cancer is expected to increase. It is important for individuals to be aware of the risks and to undergo regular breast cancer screening and diagnostic services, which can help to detect breast cancer early and improve outcomes. For example; as per the World Health Organization (WHO); the populace matured 60 years and over will increment from 1 billion in 2020 to 1.4 billion. By 2050, the world’s populace of individuals matured 60 years and older will double that is 2.1 billion.
Moreover, the growing advancement in technology is also boosting the growth of the global artificial intelligence in breast imaging market. Advances in AI and machine learning technologies have made it possible to develop more accurate and efficient algorithms for breast cancer detection. Machine learning algorithms can analyze large amounts of data and identify patterns that are not visible to the human eye, improving the accuracy of breast cancer screening and diagnosis.
For instance; on November 7th, 2022; UC Davis Teacher and Division Head of Biostatistics Diana Miglioretti got $15 million to develop and assess AI for breast cancer detection, risk model from the National Cancer Institute (NCI), the group will utilize artificial intelligence (AI) to make breast cancer screening and surveillance more exact and equitable.
However, the high cost of cancer treatments may hamper the growth of the global artificial intelligence in breast imaging market. Despite that, the growing spending on healthcare IT may provide an opportunity for the further growth of the global artificial intelligence in breast imaging market.
North America is expected to dominate the global artificial intelligence in breast imaging market within the forecast period due to the rising prevalence of breast cancer, adoption of advanced technology, and presence of key players in the region. For example; according to the American Cancer Society, in 2022, an expected 287,850 new instances of invasive breast cancer are supposed to be diagnosed in ladies in the U.S., alongside 51,400 new instances of non-invasive (in situ) breast cancer.
Also, growing adoption of advanced technology drives the market in the region. For example; in May 2022; GE Healthcare and the National Oncology Center of Singapore teamed up (NCCS). By using artificial intelligence and text handling, this joint effort aims to support the chance of more personalised cancer treatment choices and allow patients the opportunity to examine clinically significant data along the patient journey.
Asia Pacific is the fastest-growing region in the global artificial intelligence in breast imaging market because of rising breast cancer and growing healthcare infrastructure. The incidence of breast cancer is increasing rapidly in the Asia Pacific region. For example; according to Indian Cancer Society; there are about 1,70,000 new breast cancer cases in India in 2020.
Moreover, healthcare expenditure is increasing rapidly in the Asia Pacific region. Increasing healthcare expenditure is driving the adoption of AI technologies in breast imaging. AI technologies can improve the efficiency and accuracy of breast cancer detection, leading to cost savings for healthcare providers and patients.
Google Health Launched AI Partnership to Improve Breast Cancer Screening
On November 29th, 2022; Google Health & mammography artificial intelligence (AI) seller iCAD, Inc. declared a strategic partnership to integrate Google Health’s AI technology into iCAD's arrangement of breast imaging AI solutions for further develop breast cancer detection and evaluation of short-term personal cancer risk. This partnership is the initial time Google Health has authorized its mammography research model. The two organizations will likewise cooperate to improve breast cancer AI solutions for mammography and extend access to these instruments to a huge number of patients and suppliers around the world.
|2016 - 2021
|2022 - 2029
|Market Size in 2022:
|USD 348.9 Million
|Base year considered
|Forecast Period CAGR %:
|Market Size Expected in 2029:
|USD 2007.3 Million
|Tables, Charts & Figures:
|Hologic, Inc., GE Healthcare, Gamma Medica, Inc., Fujifilm Holdings Corp., Siemens Healthcare, Toshiba Corporation, Aurora Imaging Technology, Inc., QView Medical, NVIDIA Corporation, and others
|By Radiology Type, By Technique, By Application, By End User
|North America, U.S., Mexico, Canada, Europe, UK, France, Germany, Italy, Asia Pacific, China, Japan, India, Southeast Asia, South America, Brazil, Argentina, Columbia, The Middle East and Africa, GCC, Africa, Rest of the Middle East and Africa
We are always looking to hire talented individuals with equal and extraordinary proportions of industry expertise, problem solving ability and inclination interested? please email us firstname.lastname@example.orgJOIN US
BrandEssence® Market Research and Consulting Pvt ltd.
124, City Road, London EC1V 2NX
© Copyright 2024-25 BrandEssence® Market Research and Consulting Pvt ltd. All Rights Reserved | Designed by BrandEssence®